netrashetty
Netra Shetty
Quincy Newspapers, Inc. (QNI) is a family-owned media company that originated in the newspapers of Quincy, Illinois. The company's history can be traced back to 1835, when the Bounty Land Register was one of only four newspapers in all of Illinois. Over the next century, a number of mergers followed. In 1935, the Quincy Herald-Whig emerged, and it still operates under that name today. The company moved into radio in 1947 and began television broadcasts in 1953.
Shell shocked from the strain of the recession new research from Mintel finds Britain has become a nation of savers.
Indeed, it seems saving is back in vogue as in the next six months alone, as many as 70% of Brits intend to save, up from 64% last September.
Almost half (47%) of all households are saving, rising from 40% last August.
Today, some 17 million (35%) adults have less than £500 in investable assets, while 36% have between £500 and £10,000 and 29% have over £10,000.
Meanwhile, as many as 12% of Brits have over £50,000 worth of savings.
Toby Clark, Head of UK Finance at Mintel, said:
"Saving is more popular than ever, and the slowdown appears to have concentrated people's minds on the importance of saving. Huge uncertainty surrounds the outlook of 2010, making saving and debt repayment more popular than spending."
The top five reasons why Brits are saving and investing are:
1. Retirement (40%),
2. Security (39%),
3. Building an emergency fund (33%),
4. For a specific purchase (25%) and
5. Children's education (20%).
Around half of the nation's savers have relatively few (between one and two) saving products.
Savings or deposit accounts (59%) are the top investment product, with cash ISAs (34%) taking the second spot.
This is followed by a company pension (33%). Just 5% of consumers are risk takers - prepared to seek higher risks in return for higher rewards.
Although cash ISAs have shown significant growth in popularity over the past 10 years, ownership rising from around one in five in 2000 to around one in three in 2010, there still remains scope for expansion.
"Today, saving and deposit accounts are almost twice as popular as ISAs, yet there are no tax benefits for these investors. Many people do not realise that a Cash ISA can be almost as flexible as a standard savings account. For most people, it's peace of mind rather than investment returns that matter. Savers who are not making the most of their allowance are needlessly paying tax on a good chunk of their savings. With the current low interest rates, whether your savings are sheltered from tax or not can make the difference between achieving an inflation-beating return, or seeing the value of your savings eroded by the increase in prices." Toby continues.
ed States.
In order to obtain a license for marketing cosmetics, an applicant company is required to comply with GQP (“Good Quality Practice”) and GVP (“Good Vigilance Practice”) in accordance with the standards specified by MHLW (Ministry of Health, Labor, and Welfare) Ministerial Ordinances in terms of quality control and post marketing safety management. Thus, the applicant company must have a Product Quality Manager (“hinshitus hoshoh sekininsha”), a Safety Control Manager (“anzen kanri sekininsha”), and a General Marketing Business Controller (“sokatsu seisoh hanbai sekininsha”). The General Marketing Business Controller, who supervises the other two managers, must be a licensed pharmacist or a specialist who has completed university-level or equivalent pharmacology or chemistry courses. Upon receipt of the manufacturing or marketing license, the applicant company needs to file a notification of the product to be manufactured or imported and may then manufacture/import the product.
The law does not yet permit a foreign company to make direct applications from overseas for a license to market cosmetics products to Japan. Thus, a U.S. company that wishes to export its products to Japan first must find a qualified Japanese importer or representative, or set up a Japanese subsidiary. The Pharmaceutical Affairs Law also stipulates that containers or wrappers of a cosmetics product shall show the name and address of the marketer, name of product, production number or production code, name of cosmetic ingredients contained*, shelf life of cosmetics, if the product concerned is not stable for three years, and other information required by MHLW ordinance.
A full ingredient listing on the container as required in the United States was put into force in Japan on April 1, 2001. Also, MHLW implemented Positive and Negative Lists of cosmetics ingredients.
Accordingly, ingredients, the safety of which have been confirmed, can be mixed freely in a cosmetic product at the responsibility of the manufacturer or the marketer concerned, as long as the finished product meets the definition of the cosmetics described in the Pharmaceutical Affairs Law.
It is important for U.S. exporters and manufactures to note that some ingredients listed on the positive list are allowed only for limited uses in Japan, even if they have been used in other countries. For example, formaldehyde-donor-type preservatives (Imidazolidinyl Urea and DMDM Hydantoin) are not permitted in Japan, with the exception of rinse-off type products, e.g., shampoos. (Warning labels are required for products containing these preservatives.) Quaternium -15 is not approved in Japan. At the moment, suppliers who discover that their products do not meet existing standards usually seek resolution of their problems through product reformulation. This avoids complications with MHLW's strict requirements for safety and supporting data.
Please note that in Japan a quasi-drug, or “Iyakubugaihin”, is a product that has a restricted purpose of use, has a mild action on the human body, and is not categorized as a medical product. For example, medicated cosmetics, including medicated soaps, are classified under the quasi-drug category in Japan. Industry experts point out that cosmeceutical products (or medicated cosmetics) will likely be classified under the quasi-drug category. Quasi-drugs are not cosmetic products, but form an independent quasi-drug classification. The manufacture and import of quasi-drugs require MHLW approval and licenses.
The Pharmaceutical Affairs Law stipulates that quasi-drugs shall have the purposes given below and exert mild actions on the human body: 1. Prevention of nausea or other indispositions, foul breath or body odor 2. Prevention of prickly heat, soreness, and the like 3. Prevention of loss of hair, promotion of hair growth or removal of hair 4. Eradication or repellence of rats, flies, mosquitoes, fleas, etc., for the health of humans or other animals 5. Other articles designated by MHLW, complying with the items specified in the above (1 through 4).
Shell shocked from the strain of the recession new research from Mintel finds Britain has become a nation of savers.
Indeed, it seems saving is back in vogue as in the next six months alone, as many as 70% of Brits intend to save, up from 64% last September.
Almost half (47%) of all households are saving, rising from 40% last August.
Today, some 17 million (35%) adults have less than £500 in investable assets, while 36% have between £500 and £10,000 and 29% have over £10,000.
Meanwhile, as many as 12% of Brits have over £50,000 worth of savings.
Toby Clark, Head of UK Finance at Mintel, said:
"Saving is more popular than ever, and the slowdown appears to have concentrated people's minds on the importance of saving. Huge uncertainty surrounds the outlook of 2010, making saving and debt repayment more popular than spending."
The top five reasons why Brits are saving and investing are:
1. Retirement (40%),
2. Security (39%),
3. Building an emergency fund (33%),
4. For a specific purchase (25%) and
5. Children's education (20%).
Around half of the nation's savers have relatively few (between one and two) saving products.
Savings or deposit accounts (59%) are the top investment product, with cash ISAs (34%) taking the second spot.
This is followed by a company pension (33%). Just 5% of consumers are risk takers - prepared to seek higher risks in return for higher rewards.
Although cash ISAs have shown significant growth in popularity over the past 10 years, ownership rising from around one in five in 2000 to around one in three in 2010, there still remains scope for expansion.
"Today, saving and deposit accounts are almost twice as popular as ISAs, yet there are no tax benefits for these investors. Many people do not realise that a Cash ISA can be almost as flexible as a standard savings account. For most people, it's peace of mind rather than investment returns that matter. Savers who are not making the most of their allowance are needlessly paying tax on a good chunk of their savings. With the current low interest rates, whether your savings are sheltered from tax or not can make the difference between achieving an inflation-beating return, or seeing the value of your savings eroded by the increase in prices." Toby continues.
ed States.
In order to obtain a license for marketing cosmetics, an applicant company is required to comply with GQP (“Good Quality Practice”) and GVP (“Good Vigilance Practice”) in accordance with the standards specified by MHLW (Ministry of Health, Labor, and Welfare) Ministerial Ordinances in terms of quality control and post marketing safety management. Thus, the applicant company must have a Product Quality Manager (“hinshitus hoshoh sekininsha”), a Safety Control Manager (“anzen kanri sekininsha”), and a General Marketing Business Controller (“sokatsu seisoh hanbai sekininsha”). The General Marketing Business Controller, who supervises the other two managers, must be a licensed pharmacist or a specialist who has completed university-level or equivalent pharmacology or chemistry courses. Upon receipt of the manufacturing or marketing license, the applicant company needs to file a notification of the product to be manufactured or imported and may then manufacture/import the product.
The law does not yet permit a foreign company to make direct applications from overseas for a license to market cosmetics products to Japan. Thus, a U.S. company that wishes to export its products to Japan first must find a qualified Japanese importer or representative, or set up a Japanese subsidiary. The Pharmaceutical Affairs Law also stipulates that containers or wrappers of a cosmetics product shall show the name and address of the marketer, name of product, production number or production code, name of cosmetic ingredients contained*, shelf life of cosmetics, if the product concerned is not stable for three years, and other information required by MHLW ordinance.
A full ingredient listing on the container as required in the United States was put into force in Japan on April 1, 2001. Also, MHLW implemented Positive and Negative Lists of cosmetics ingredients.
Accordingly, ingredients, the safety of which have been confirmed, can be mixed freely in a cosmetic product at the responsibility of the manufacturer or the marketer concerned, as long as the finished product meets the definition of the cosmetics described in the Pharmaceutical Affairs Law.
It is important for U.S. exporters and manufactures to note that some ingredients listed on the positive list are allowed only for limited uses in Japan, even if they have been used in other countries. For example, formaldehyde-donor-type preservatives (Imidazolidinyl Urea and DMDM Hydantoin) are not permitted in Japan, with the exception of rinse-off type products, e.g., shampoos. (Warning labels are required for products containing these preservatives.) Quaternium -15 is not approved in Japan. At the moment, suppliers who discover that their products do not meet existing standards usually seek resolution of their problems through product reformulation. This avoids complications with MHLW's strict requirements for safety and supporting data.
Please note that in Japan a quasi-drug, or “Iyakubugaihin”, is a product that has a restricted purpose of use, has a mild action on the human body, and is not categorized as a medical product. For example, medicated cosmetics, including medicated soaps, are classified under the quasi-drug category in Japan. Industry experts point out that cosmeceutical products (or medicated cosmetics) will likely be classified under the quasi-drug category. Quasi-drugs are not cosmetic products, but form an independent quasi-drug classification. The manufacture and import of quasi-drugs require MHLW approval and licenses.
The Pharmaceutical Affairs Law stipulates that quasi-drugs shall have the purposes given below and exert mild actions on the human body: 1. Prevention of nausea or other indispositions, foul breath or body odor 2. Prevention of prickly heat, soreness, and the like 3. Prevention of loss of hair, promotion of hair growth or removal of hair 4. Eradication or repellence of rats, flies, mosquitoes, fleas, etc., for the health of humans or other animals 5. Other articles designated by MHLW, complying with the items specified in the above (1 through 4).
Last edited: